The recombinant TAS2R39 is employed in studies to elucidate its ligand interactions, signaling mechanisms, and physiological roles.
TAS2R39 binds a diverse range of plant-derived compounds, including:
Agonists: Theaflavins (e.g., theaflavin-3,3-O’-digalatte), catechins (e.g., epigallocatechin gallate), and isoflavones (e.g., genistein derivatives) .
Example Ligand Specificity:
| Ligand Type | Examples | Receptor Selectivity | Source |
|---|---|---|---|
| Agonists | Theaflavins, catechins, genistein | TAS2R39-specific (e.g., acetylgenistin) | |
| Antagonists | Acacetin, 5,2′-dihydroxyflavone | Broad TAS2R inhibition |
TAS2R39 activates Gα-gustducin, triggering calcium mobilization and cAMP signaling . In extraoral tissues (e.g., gastrointestinal tract), it regulates enterohormones and modulates food intake .
TAS2R39 exhibits conserved functions across primates but differs in ligand specificity compared to human orthologs.
Despite its utility, challenges remain:
Limited Antagonists: Few selective antagonists are available, hindering functional studies .
Low Tissue Expression: Detection in native tissues is challenging due to low mRNA/protein levels .
Evolutionary Insights: Further studies are needed to explore its role in dietary adaptation, particularly in primates with specialized diets .
KEGG: mcc:705958
UniGene: Mmu.16487
Macaca mulatta TAS2R39 is a G-protein coupled receptor belonging to the taste receptor type 2 family. It is a full-length protein comprising 338 amino acids, characterized by a seven-transmembrane domain structure typical of taste receptors. The protein has a Uniprot accession number of Q645S5 and contains the complete amino acid sequence starting with MLGRCFPPNTKE and ending with HLYPKQWTL. Like other T2R family members, it likely functions through signal transduction pathways involving gustducin activation.
For optimal preservation of recombinant Macaca mulatta TAS2R39, the protein should be stored at -20°C in a Tris-based buffer containing 50% glycerol. For extended storage periods, maintaining the protein at -80°C is recommended. It is crucial to avoid repeated freeze-thaw cycles as these can significantly compromise protein integrity. For short-term use (up to one week), working aliquots can be stored at 4°C. This approach minimizes structural degradation and maintains functional activity for experimental applications.
When designing experiments to investigate TAS2R39 function, researchers should consider several critical parameters:
Protein concentration optimization: Titrate recombinant TAS2R39 to determine optimal working concentrations (typically starting with the provided 50 μg quantity).
Buffer composition: Ensure compatibility with downstream applications by evaluating the effects of the Tris-based storage buffer containing 50% glycerol.
Temperature conditions: Maintain consistent temperature parameters that reflect physiological conditions (typically 37°C for functional assays).
Control experiments: Include both positive controls (known bitter compound receptors) and negative controls (buffer-only or irrelevant proteins).
Detection methods: Implement appropriate assays to measure receptor activation, such as calcium imaging, bioluminescence resonance energy transfer (BRET), or reporter gene assays.
This methodological framework enables robust investigation of TAS2R39 functionality while minimizing experimental variability.
Comparative studies between human and Macaca mulatta taste receptors require a systematic approach:
Sequence alignment analysis: Perform comprehensive sequence alignments to identify conserved and divergent regions between human and macaque taste receptors. Focus on transmembrane domains and ligand-binding regions.
Functional conservation testing: Employ identical experimental conditions when testing both human and macaque receptors, using standardized ligand panels.
Expression system consistency: Utilize the same heterologous expression systems (e.g., HEK293 cells) for both receptor types to eliminate system-dependent variables.
Phylogenetic analysis: Incorporate evolutionary context by constructing phylogenetic trees of taste receptor genes across primate species.
Statistical methods: Apply appropriate statistical tests for cross-species comparisons, accounting for potential differences in receptor density and signaling efficiency.
This approach allows for meaningful comparative analysis while controlling for species-specific variations in receptor function and expression.
To determine the ligand specificity of TAS2R39, researchers can employ multiple complementary approaches:
Calcium mobilization assays: Measure intracellular calcium release upon receptor activation using fluorescent calcium indicators (Fura-2 or Fluo-4) in cells expressing TAS2R39.
Receptor internalization studies: Track receptor trafficking upon ligand binding using fluorescently-tagged TAS2R39.
Competitive binding assays: Utilize radiolabeled or fluorescently-labeled known ligands to assess competitive binding of candidate compounds.
Molecular docking simulations: Employ in silico approaches to predict binding affinities of potential ligands based on the receptor's structural model.
Site-directed mutagenesis: Systematically alter key amino acid residues to identify critical binding sites and confirm predicted interactions.
These methodologies should be implemented in a hierarchical manner, starting with broad screening approaches and progressively focusing on detailed characterization of specific ligand-receptor interactions.
Like other taste receptors, TAS2R39 likely serves functions beyond oral taste perception. Emerging research on taste receptors suggests potential roles in:
Gastrointestinal chemosensing: TAS2R39 may detect bitter compounds in the digestive tract, triggering protective responses such as reduced gastric emptying or increased secretion of satiety hormones.
Respiratory epithelium: The receptor might participate in airway defense mechanisms by detecting irritants and initiating bronchodilation or increased ciliary beat frequency.
Immune modulation: TAS2R39 could influence immune cell function, potentially affecting inflammatory responses when activated by specific compounds.
Endocrine signaling: The receptor may participate in hormone release regulation in various endocrine tissues, similar to findings with other taste receptors.
Neurological functions: TAS2R39 could have roles in the central nervous system, potentially affecting behaviors related to appetite or aversion.
Investigation of these extra-oral roles requires tissue-specific expression analysis combined with functional assays in relevant cell types and physiological models.
To investigate associations between TAS2R39 genetic variants and disease susceptibility, researchers should implement a multi-faceted approach:
Genome-wide association studies (GWAS): Identify potential correlations between TAS2R39 polymorphisms and disease phenotypes in large population cohorts.
Case-control studies: Compare the frequency of specific TAS2R39 variants between affected individuals and matched controls.
Functional characterization: Assess the impact of identified variants on receptor function using in vitro expression systems.
Transgenic animal models: Generate models expressing variant forms of TAS2R39 to evaluate physiological consequences in vivo.
Clinical correlation analysis: Investigate relationships between receptor genotypes, taste perception phenotypes, and clinical outcomes.
This comprehensive strategy can reveal meaningful associations while distinguishing causative relationships from mere correlations, providing insights into potential therapeutic applications.
Evolutionary analysis of TAS2R39 can provide valuable insights into primate dietary adaptations through several methodological approaches:
Comparative genomics: Analyze TAS2R39 sequences across primate species, identifying signatures of positive selection, purifying selection, or relaxed constraints.
Ecological correlation studies: Associate TAS2R39 genetic variants with dietary specializations among different primate species and populations.
Ancestral sequence reconstruction: Infer ancestral TAS2R39 sequences to track evolutionary changes coinciding with dietary shifts in primate evolution.
Ligand response profiling: Compare the response profiles of TAS2R39 from different primate species to ecologically relevant bitter compounds.
Structural modeling: Analyze how evolutionary changes in amino acid sequence affect the predicted binding pocket and receptor functionality.
This evolutionary perspective can reveal how selective pressures from diet have shaped taste receptor function across primate lineages and potentially inform research on human taste preference variations.
Expression and purification of functional recombinant TAS2R39 presents several technical challenges that researchers must address:
Membrane protein solubility: As a seven-transmembrane protein, TAS2R39 has hydrophobic domains that complicate expression in aqueous solutions. Solution: Use specialized detergents or nanodiscs to maintain proper folding and solubility.
Post-translational modifications: Ensure that expression systems provide appropriate glycosylation and other modifications. Solution: Select mammalian expression systems like HEK293 or CHO cells rather than bacterial systems.
Low expression yields: Membrane proteins often express at lower levels than soluble proteins. Solution: Optimize codon usage for the expression system and use inducible promoters to control expression timing.
Protein verification: Confirming proper folding and functionality can be challenging. Solution: Implement activity-based assays and structural verification through circular dichroism or limited proteolysis.
Stability during purification: Maintaining functional integrity throughout purification steps. Solution: Include stabilizing agents like glycerol (as noted in the 50% glycerol storage buffer) and perform purification steps at 4°C.
Addressing these challenges through methodical optimization is essential for obtaining biologically relevant results in TAS2R39 research.
Designing effective experiments to study TAS2R39 in the context of taste perception variability requires a comprehensive approach:
Subject recruitment and phenotyping: Implement standardized taste perception tests, similar to the Harris and Kalmus method using decreasing concentrations of bitter compounds until subjects perceive the solution as water.
Genotyping protocols: Sequence the TAS2R39 gene to identify polymorphisms that may correlate with perception differences.
Taste receptor density quantification: Assess the density of taste receptors on subjects' tongues, as receptor density has been correlated with taste intensity perception (r = 0.84; P < 0.001 in studies of related taste receptors).
Psychophysical testing standardization: Develop consistent protocols for measuring threshold detection, perceived intensity, and hedonic responses.
Cross-modal sensory integration: Investigate how TAS2R39-mediated bitter perception interacts with other sensory modalities.
This experimental design framework allows for robust investigation of the relationship between TAS2R39 genetic variation and phenotypic taste perception differences while controlling for confounding variables.
When analyzing data from TAS2R39 functional studies, researchers should consider these statistical approaches based on specific experimental designs:
| Experimental Design | Recommended Statistical Analysis | Advantages | Considerations |
|---|---|---|---|
| Dose-response studies | Non-linear regression (EC50/IC50 determination) | Quantifies receptor sensitivity | Requires sufficient data points across concentration range |
| Genetic association studies | Chi-square tests, odds ratios, logistic regression | Identifies correlations between variants and phenotypes | Needs appropriate sample size for statistical power |
| Comparative receptor studies | ANOVA with post-hoc tests, t-tests for pairwise comparisons | Allows comparison across multiple receptor variants | Control for multiple comparisons (e.g., Bonferroni correction) |
| Time-course experiments | Repeated measures ANOVA, mixed-effects models | Accounts for temporal dependencies in the data | Must address potential autocorrelation |
| Receptor trafficking studies | Survival analysis techniques, compartmental modeling | Captures dynamic aspects of receptor function | Requires specialized software for complex models |
Proper statistical analysis should include sample size determination, power analysis, normality testing, and appropriate data transformation when necessary. For reproducibility, researchers should report all statistical parameters completely, including test statistics, degrees of freedom, and exact p-values.
CRISPR-Cas9 gene editing offers powerful approaches for studying TAS2R39 function in vivo through several methodological strategies:
Knockout models: Generate TAS2R39-null Macaca mulatta models to assess the specific contribution of this receptor to bitter taste perception and potential extra-oral functions.
Knock-in modifications: Introduce specific mutations or humanized versions of TAS2R39 to study structure-function relationships and species differences.
Reporter tagging: Add fluorescent or luminescent tags to endogenous TAS2R39 to track expression patterns and receptor trafficking in live tissues.
Conditional expression systems: Implement tissue-specific or temporally-controlled TAS2R39 expression to dissect its role in different physiological contexts.
Single-cell analysis: Combine CRISPR editing with single-cell RNA sequencing to identify cell-specific effects of TAS2R39 modification.
These gene editing approaches provide unprecedented specificity for investigating TAS2R39 function within the complex physiological environment of the whole organism, offering insights not achievable with in vitro systems alone.
Research on TAS2R39 could lead to several promising drug discovery applications:
Taste masking technologies: Understanding TAS2R39 ligand interactions could inform the development of compounds that block bitter taste perception, improving medication compliance.
Gastrointestinal therapeutics: If TAS2R39 functions in gut chemosensing, it could serve as a target for modulating digestive processes, appetite, or nutrient absorption.
Respiratory disease treatments: Given the expression of taste receptors in airway cells, TAS2R39 agonists might have bronchodilatory effects beneficial in asthma or COPD.
Cancer therapies: If TAS2R39 shows expression patterns in tumor cells similar to those observed with TAS2R38 in pancreatic cancer, it could represent a novel therapeutic target.
Metabolic disease interventions: TAS2R39's potential role in hormone release or nutrient sensing could be leveraged for treating metabolic disorders.
These applications would require initial validation of TAS2R39 expression in relevant tissues, confirmation of functional effects, and development of highly specific agonists or antagonists.
Integrating computational modeling with experimental approaches can significantly accelerate TAS2R39 research through several synergistic methodologies:
Structure prediction and refinement: Use homology modeling and molecular dynamics simulations to predict TAS2R39 structure, generating testable hypotheses about ligand binding sites.
Virtual screening: Employ in silico docking of compound libraries to identify potential TAS2R39 ligands for experimental validation, narrowing the field of candidates.
Machine learning approaches: Develop predictive models of TAS2R39 activation based on chemical features of known ligands, facilitating the discovery of novel modulators.
Systems biology integration: Model TAS2R39 within broader signaling networks to understand its physiological impact in different tissues and conditions.
Evolutionary analysis: Apply computational phylogenetics to trace TAS2R39 evolution across primates, correlating sequence changes with ecological and dietary shifts.
This integrated approach creates an iterative research cycle where computational predictions guide experimental design, and experimental results refine computational models, accelerating discovery while minimizing resource expenditure.